Related Experiment Video
Updated: Aug 24, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Is heart failure different on the two continents (North America and Europe)?
Rachel Hughes-Doichev1, Mark E Dunlap
1Case Western Reserve University, Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA.
Insights
Heart failure is rising globally, with heart failure with preserved systolic function becoming more prevalent. Older adults need more clinical trials to ensure treatments are safe and effective for this growing population.
Area of Science:
- Cardiology
- Epidemiology
- Geriatrics
Background:
- Rising incidence of heart failure globally, particularly in North America and Europe.
- Increasing recognition of heart failure with preserved systolic function (HFpEF).
- HFpEF is linked to hypertension, aging, and female sex.
Purpose of the Study:
- Compare heart failure similarities and differences between North America and Europe.
- Analyze the characteristics and treatment of HFpEF.
- Highlight the need for geriatric-focused clinical trials in heart failure.
Main Methods:
- Comparative analysis of heart failure epidemiology and treatment guidelines across continents.
- Review of patient demographics and comorbidities associated with HFpEF.
- Assessment of current clinical trial populations.
Main Results:
- Similarities and differences in heart failure prevalence and characteristics exist between North America and Europe.
- HFpEF is a significant and growing concern on both continents.
- Treatment guidelines show more similarities than differences, but treatment patterns vary.
Conclusions:
- Heart failure management requires attention to continental differences and similarities.
- The increasing prevalence of HFpEF necessitates tailored research.
- Future heart failure clinical trials must adequately represent the aging population to ensure treatment efficacy and safety.
Abstract:
Heart failure is increasing in both North America and Europe. Although many similarities in the disease are apparent between the two continents, differences do exist. Heart failure with preserved systolic function appears to be increasingly important on both continents, and is associated more frequently with hypertension, aging, and female sex. Treatment guidelines from the two continents show more similarities than differences, though different treatment patterns emerge. Because more patients with heart failure will be older in the future, clinical trials that include greater numbers of these patients are needed to demonstrate that therapies are as effective and safe in this population.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions